Bellevue Group AG

Q4 2019 13F-HR Detailed Holdings

Location
Kuesnacht, V8
Holdings as of
12/31/2019
Date filed
2/14/2020
Form type
13F-HR
Num holdings
239
Total value ($000)
$6,307,401
Net value change ($000)
—
New positions
214
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: — Next filing: 5/14/2020 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IONS 509,366 —
NBIX 356,692 —
INCY 307,104 —
VRTX 304,185 —
ESPR 269,826 —
ALNY 214,767 —
AGIO 187,417 —
ARGX 156,070 —
ALXN 150,212 —
HALO 142,493 —
Top Reduces (Value $000, Stocks/ETFs)
—
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 8 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892